{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T09:42:21Z","timestamp":1786268541425,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003945","name":"Link\u00f6ping University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Designer benzodiazepines (DBZDs) are a class of new psychoactive substances (NPS) designed as legal alternatives to prescription BZDs. Bromazolam has been the most prevalent DBZD detected on the recreational market around the world; however, a new DBZD, ethylbromazolam (8-bromo-1-ethyl-6-phenyl-4\u00a0H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; also known as bromoethylazolam) has recently emerged. In this study, the emergence of ethylbromazolam in Canada, the UK, and Australia is reported based on analysis of samples from drug checking services and in Germany based on analysis of samples seized by customs and mail services. Since November 2024, ethylbromazolam has been increasingly detected with a concurrent decrease in bromazolam detections, suggesting that its emergence is likely in response to the international control of bromazolam on 3rd December 2024. Additionally, increased detections of other DBZDs, including desalkylgidazepam (bromonordiazepam) and clobromazolam (phenazolam) have been recently observed. The in vitro \u03b1\n                    <jats:sub>1<\/jats:sub>\n                    \u03b2\n                    <jats:sub>2<\/jats:sub>\n                    \u03b3\n                    <jats:sub>2<\/jats:sub>\n                    GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor activity of ethylbromazolam was determined using an automated patch clamp assay. Ethylbromazolam was found to have similar in vitro GABA\n                    <jats:sub>A<\/jats:sub>\n                    receptor activity as bromazolam (EC\n                    <jats:sub>50<\/jats:sub>\n                    of 10.1 nM and 15.2 nM, respectively), indicating comparable pharmacological activity and potential for harm. The market should continue to be monitored closely as it continues to evolve in response to the control of bromazolam.\n                  <\/jats:p>","DOI":"10.1007\/s00204-026-04433-9","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T09:33:38Z","timestamp":1779269618000},"page":"4065-4076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global emergence and \u03b3-aminobutyric acid type A (GABAA) receptor activity of the new designer benzodiazepine ethylbromazolam"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-0367","authenticated-orcid":false,"given":"Caitlyn","family":"Norman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Acreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Bissram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-3938","authenticated-orcid":false,"given":"Blake","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Hamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folker","family":"Westphal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-6804","authenticated-orcid":false,"given":"Michael","family":"Putz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4038-2118","authenticated-orcid":false,"given":"Cristiana","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9044-1093","authenticated-orcid":false,"given":"Rick","family":"Lines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2343-3226","authenticated-orcid":false,"given":"Malcolm D.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-5728","authenticated-orcid":false,"given":"Henrik","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"issue":"1","key":"4433_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2018.7399","volume":"2","author":"SD Agarwal","year":"2019","unstructured":"Agarwal SD, Landon BE (2019) Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw Open 2(1):1\u201311. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7399","journal-title":"JAMA Netw Open"},{"issue":"10","key":"4433_CR2","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1002\/dta.3637","volume":"16","author":"JL Algar","year":"2024","unstructured":"Algar JL, Lawes DJ, Carroll AJ, Caldicott D, McLeod MD (2024) Identification of three unexpected new psychoactive substances at an Australian drug checking service. Drug Test Anal 16(10):1144\u20131154. https:\/\/doi.org\/10.1002\/dta.3637","journal-title":"Drug Test Anal"},{"key":"4433_CR3","doi-asserted-by":"publisher","unstructured":"Batlle E, Lizano E, Vi\u00f1as M, Pujol MD (2018) 1,4-Benzodiazepines and new derivatives: description, analysis, and organic synthesis. In J. Va\u0161kov\u00e1 & L. Va\u0161ko (eds) Medicinal Chemistry. InTechOpen. https:\/\/doi.org\/10.5772\/intechopen.79879","DOI":"10.5772\/intechopen.79879"},{"issue":"9","key":"4433_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/jat\/bkae074","volume":"48","author":"JJ Bierly","year":"2024","unstructured":"Bierly JJ, Papsun DM, Logan BK (2024) Bromazolam in impaired driving investigations. J Anal Toxicol 48(9):653\u2013658. https:\/\/doi.org\/10.1093\/jat\/bkae074","journal-title":"J Anal Toxicol"},{"issue":"6","key":"4433_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1111\/bcp.13570","volume":"84","author":"CA Cadogan","year":"2018","unstructured":"Cadogan CA, Ryan C, Cahir C, Bradley CP, Bennett K (2018) Benzodiazepine and Z-drug prescribing in Ireland: analysis of national prescribing trends from 2005 to 2015. Br J Clin Pharmacol 84(6):1354\u20131363. https:\/\/doi.org\/10.1111\/bcp.13570","journal-title":"Br J Clin Pharmacol"},{"key":"4433_CR6","unstructured":"Cantestcbr (2025) Ethylbromazolam found in expected alprazolam pills. Instagram. https:\/\/www.instagram.com\/p\/DKbToy7PJkU\/?img_index=1"},{"issue":"10","key":"4433_CR7","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1002\/dta.3910","volume":"17","author":"B Curtis","year":"2025","unstructured":"Curtis B, Lawes DJ, Caldicott D, McLeod MD (2025) Identification of the novel synthetic opioid N-pyrrolidino isotonitazene at an Australian drug checking service. Drug Test Anal 17(10):1996\u20132004. https:\/\/doi.org\/10.1002\/dta.3910","journal-title":"Drug Test Anal"},{"key":"4433_CR8","unstructured":"Do we have any type of comparison on dosages of ethylbromazolam yet? (2025) Reddit. https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/1pfrok2\/do_we_have_any_type_of_comparison_on_dosages_for\/"},{"key":"4433_CR9","unstructured":"Drugchecking (2025) February 22 - March 7, 2025 Bi-weekly report. Instagram. https:\/\/www.instagram.com\/p\/DHElJl2pZhS\/?img_index=3"},{"key":"4433_CR10","unstructured":"Drugs.com (2025) MYLAN A4 Pill: white, round, 10mm. https:\/\/www.drugs.com\/imprints\/mylan-a4-7274.html"},{"key":"4433_CR11","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2025.2524078","author":"LC Dunlop","year":"2025","unstructured":"Dunlop LC, Craik V, Jarvie N, Hudson S, Walters M, Dear JW, Lowe DJ (2025) Clinical characterisation of the novel benzodiazepine bromazolam: data from the ASSIST (a surveillance study of illicit substance toxicity) study. Clin Toxicol. https:\/\/doi.org\/10.1080\/15563650.2025.2524078","journal-title":"Clin Toxicol"},{"issue":"3","key":"4433_CR12","doi-asserted-by":"publisher","first-page":"648","DOI":"10.3390\/neurolint14030053","volume":"14","author":"AN Edinoff","year":"2022","unstructured":"Edinoff AN, Nix CA, Odisho AS, Babin CP, Derouen AG, Lutfallah SC, Cornett EM, Murnane KS, Kaye AM, Kaye AD (2022) Novel designer benzodiazepines: comprehensive review of evolving clinical and adverse effects. Neurol Int 14(3):648\u2013663. https:\/\/doi.org\/10.3390\/neurolint14030053","journal-title":"Neurol Int"},{"issue":"5253","key":"4433_CR13","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.15585\/mmwr.mm725253a5","volume":"72","author":"PF Ehlers","year":"2024","unstructured":"Ehlers PF, Deitche A, Wise LM, Patrick SL, Holloway-Beth A, Ellison R, Trecki J, Gerona R, Wahl MS (2024) Notes from the Field: Seizures, Hyperthermia, and Myocardial Injury in Three Young Adults Who Consumed Bromazolam Disguised as Alprazolam \u2014 Chicago, Illinois, February 2023. Morb Mortal Wkly Rep 72(5253):1392\u20131393. https:\/\/doi.org\/10.15585\/mmwr.mm725253a5","journal-title":"Morb Mortal Wkly Rep"},{"issue":"1","key":"4433_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/jat\/bkae079","volume":"49","author":"KN Ellefsen","year":"2025","unstructured":"Ellefsen KN, Smith CR, Simmons PD, Edelman LA, Hall BJ (2025) The rise of bromazolam in postmortem cases fromTravis County,TX, and surrounding areas: 2021 to 2023. J Anal Toxicol 49(1):43\u201352. https:\/\/doi.org\/10.1093\/jat\/bkae079","journal-title":"J Anal Toxicol"},{"key":"4433_CR16","unstructured":"Ethylbromazolam experience (2025) Reddit. https:\/\/www.reddit.com\/r\/researchchemicals\/comments\/1mngffo\/ethylbromazolam_experience\/"},{"key":"4433_CR15","unstructured":"Ethylbromazolam \/ Bromoethylazolam is by far the #1 RC right now (2025) Reddit. https:\/\/www.reddit.com\/r\/rcbenzos4\/comments\/1nv246o\/ethylbromazolam_bromoethylazolam_is_by_far_the_1\/"},{"key":"4433_CR17","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2021) New benzodiazepines in Europe: a review. https:\/\/doi.org\/10.2810\/725973","DOI":"10.2810\/725973"},{"key":"4433_CR18","doi-asserted-by":"publisher","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2024) European drug report 2024: trends and developments. https:\/\/doi.org\/10.2810\/91693","DOI":"10.2810\/91693"},{"key":"4433_CR19","unstructured":"Field GF, Sternback LH, Zally WJ (1971) 1,4-benzodiazepin-5-ones and methods for the preparation thereof. US3678038A. United States Patents"},{"issue":"123","key":"4433_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43141-021-00224-0","volume":"19","author":"A Ghit","year":"2021","unstructured":"Ghit A, Assal D, Al-Shami AS, Hussein DEE (2021) GABAA receptors: structure, function, pharmacology, and related disorders. J Genetic Eng Biotechnol 19(123):1\u201315. https:\/\/doi.org\/10.1186\/s43141-021-00224-0","journal-title":"J Genetic Eng Biotechnol"},{"key":"4433_CR21","unstructured":"Healthdirect Australia. (2026). Paxam. Retrieved September 16 (2025) from https:\/\/www.healthdirect.gov.au\/medicines\/brand\/amt,3163011000036108\/paxam"},{"key":"4433_CR22","unstructured":"High Alert (2025) New benzodiazepine ethylbromazolam detected in New Zealand. https:\/\/www.highalert.org.nz\/alerts-and-notifications\/new-benzodiazepine-ethylbromazolam-detected-in-new-zealand\/"},{"issue":"111891","key":"4433_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2023.111891","volume":"354","author":"LJ Hikin","year":"2024","unstructured":"Hikin LJ, Coombes G, Rice-davies K, Couchman L, Smith PR, Morley SR (2024) Post mortem blood bromazolam concentrations and co-findings in 96 coronial cases within England and Wales. Forensic Sci Int 354(111891):1\u20135. https:\/\/doi.org\/10.1016\/j.forsciint.2023.111891","journal-title":"Forensic Sci Int"},{"key":"4433_CR24","unstructured":"International Narcotics Control Board (2024) New Substances 2024. https:\/\/www.incb.org\/documents\/Psychotropics\/PSY_New_Substances_2024_ENG.pdf"},{"issue":"1\u20132","key":"4433_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2012.07.004","volume":"125","author":"JD Jones","year":"2012","unstructured":"Jones JD, Mogali S, Comer SD (2012) Polydrug abuse: a review of opioid and benzodiazepine combination use. Drug Alcohol Depend 125(1\u20132):8\u201318. https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.07.004","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"4433_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1176\/appi.ps.201700095","volume":"69","author":"CN Kaufmann","year":"2018","unstructured":"Kaufmann CN, Spira AP, Depp CA, Mojtabai R (2018) Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999\u20132014. Psychiatric Serv 69(2):235\u2013238. https:\/\/doi.org\/10.1176\/appi.ps.201700095","journal-title":"Psychiatric Serv"},{"issue":"6","key":"4433_CR27","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1159\/000502518","volume":"25","author":"H L\u00f3pez-Pelayo","year":"2019","unstructured":"L\u00f3pez-Pelayo H, Coma A, Gual A, Zara C, Lligo\u00f1a A (2019) Call for action: benzodiazepine prescription prevalence analysis shows off-label prescription in one in eleven citizens. Eur Addict Res 25(6):320\u2013329. https:\/\/doi.org\/10.1159\/000502518","journal-title":"Eur Addict Res"},{"issue":"5","key":"4433_CR28","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/dta.3560","volume":"16","author":"V Marland","year":"2024","unstructured":"Marland V, Reid R, Brandon AM, Hill K, Cruickshanks F, McKenzie C, Norman C, Nic Da\u00e9id N, M\u00e9nard H (2024) Changing trends in novel benzodiazepine use within Scottish prisons: detection, quantitation, prevalence, and modes of use. Drug Test Anal 16(5):457\u2013472. https:\/\/doi.org\/10.1002\/dta.3560","journal-title":"Drug Test Anal"},{"issue":"103512","key":"4433_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugpo.2021.103512","volume":"100","author":"A McAuley","year":"2022","unstructured":"McAuley A, Matheson C, Robertson JR (2022) From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic. Int J Drug Policy 100(103512):1\u20137. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103512","journal-title":"Int J Drug Policy"},{"key":"4433_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/jat\/bkad005","volume":"47","author":"SAM M\u00e9rette","year":"2023","unstructured":"M\u00e9rette SAM, Th\u00e9riault S, Piramide LEC, Davis MD, Shapiro AM (2023) Bromazolam blood concentrations in postmortem cases: a British Columbia perspective. J Anal Chem 47:385\u2013392. https:\/\/doi.org\/10.1093\/jat\/bkad005","journal-title":"J Anal Chem"},{"issue":"7","key":"4433_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40261-016-0397-8","volume":"36","author":"Y Murphy","year":"2016","unstructured":"Murphy Y, Wilson E, Goldner EM, Fischer B (2016) Benzodiazepine use, misuse, and harm at the population level in Canada: a comprehensive narrative review of data and developments since 1995. Clin Drug Investig 36(7):519\u2013530. https:\/\/doi.org\/10.1007\/s40261-016-0397-8","journal-title":"Clin Drug Investig"},{"key":"4433_CR32","unstructured":"National Institute for Health and Care Excellence (2020) Generalised anxiety disorder and panic disorder in adults: management. https:\/\/www.nice.org.uk\/guidance\/cg113"},{"key":"4433_CR33","unstructured":"NETZWERK ADEBAR (2026) ADEBAR-Projekt. Retrieved February 25 (2026) from https:\/\/www.projekt-adebar.eu\/"},{"key":"4433_CR34","doi-asserted-by":"crossref","unstructured":"Norman C, Liin SI, Miguel AJ, Ottosson NE, Green H (2026) In vitro \u03b3-aminobutyric acid A (GABAA) receptor activity and binding interactions at the \u03b1+\/\u03b32\u2013 interface of 53 prescription and designer benzodiazepines. Communications Chemistry 9(155):1-19. https:\/\/doi.org\/10.1038\/s42004-026-02001-x","DOI":"10.1038\/s42004-026-02001-x"},{"key":"4433_CR35","unstructured":"NPS Discovery (2025) Ethylbromazolam. https:\/\/www.cfsre.org\/images\/monographs\/Ethylbromazolam-New-Drug-Monograph-NPS-Discovery.pdf"},{"key":"4433_CR36","unstructured":"NPS MedicineWise (2024) Antenex. https:\/\/www.nps.org.au\/medicine-finder\/antenex-tablets"},{"key":"4433_CR37","unstructured":"Public Health Nigeria (2020) MSJ pill: Uses, side effects, addiction, street names. https:\/\/www.publichealth.com.ng\/msj-pill-uses-side-effects-addiction-street-names\/"},{"issue":"8","key":"4433_CR38","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/dta.3280","volume":"14","author":"B Pulver","year":"2022","unstructured":"Pulver B, Fischmann S, Westphal F, Sch\u00f6nberger T, Sch\u00e4per J, Budach D, Jacobsen-Bauer A, Dreiseitel W, Zagermann J, Damm A, Knecht S, Opatz T, Auw\u00e4rter V, P\u00fctz M (2022) The ADEBAR project: European and international provision of analytical data from structure elucidation and analytical characterization of NPS. Drug Test Anal 14(8):1491\u20131502. https:\/\/doi.org\/10.1002\/dta.3280","journal-title":"Drug Test Anal"},{"issue":"8","key":"4433_CR39","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/add.16520","volume":"119","author":"LN Rodda","year":"2024","unstructured":"Rodda LN (2024) The surge of bromazolam-related fatalities replacing other novel designer benzodiazepines-related fatalities in San Francisco. Addiction 119(8):1487\u20131490. https:\/\/doi.org\/10.1111\/add.16520","journal-title":"Addiction"},{"issue":"3","key":"4433_CR40","doi-asserted-by":"publisher","first-page":"120","DOI":"10.9740\/mhc.2016.05.120","volume":"6","author":"A Schmitz","year":"2016","unstructured":"Schmitz A (2016) Benzodiazepine use, misuse, and abuse: a review. Mental Health Clinician 6(3):120\u2013126. https:\/\/doi.org\/10.9740\/mhc.2016.05.120","journal-title":"Mental Health Clinician"},{"issue":"1","key":"4433_CR41","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1002\/cpph.75","volume":"89","author":"M Schupp","year":"2020","unstructured":"Schupp M, Park SH, Qian B, Yu W (2020) Electrophysiological studies of GABAA receptors using QPatch II, the next generation of automated patch-clamp instruments. Curr Protocols Pharmacol 89(1):e75. https:\/\/doi.org\/10.1002\/cpph.75","journal-title":"Curr Protocols Pharmacol"},{"issue":"8","key":"4433_CR42","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s11606-017-4059-1","volume":"32","author":"MA Steinman","year":"2017","unstructured":"Steinman MA, Low M, Balicer RD, Shadmi E (2017) Epidemic use of benzodiazepines among older adults in Israel: epidemiology and leverage points for improvement. J Gen Intern Med 32(8):891\u2013899. https:\/\/doi.org\/10.1007\/s11606-017-4059-1","journal-title":"J Gen Intern Med"},{"key":"4433_CR43","unstructured":"Substance Misuse Resources (2026) MSJ\/Diazepam guide. Retrieved March 24 (2023) from https:\/\/www.substancemisuseresources.co.uk\/harm-reduction-information\/msj-diazepam-guide"},{"key":"4433_CR44","unstructured":"The Royal Australian and New Zealand College of Psychiatrists (2019) Professional Practice guideline 5: guidance for the use of benzodiazepines in psychiatric practice. https:\/\/www.ranzcp.org\/getmedia\/cf85cf1c-b983-412d-b13d-0c7d384e0af0\/ppg-5-use-of-benzodiazepines.pdf"},{"key":"4433_CR45","unstructured":"Toronto\u2019s Drug Checking Service (2026) Toronto\u2019s drug checking service. Retrieved February 25 (2026) from https:\/\/drugchecking.community\/"},{"key":"4433_CR46","unstructured":"Toronto\u2019s Drug Checking Service (2026) 121 samples checked: February 7\u201320, 2026. Toronto\u2019s Drug Checking Service. https:\/\/drugchecking.community\/report\/february-7-20-2026\/"},{"key":"4433_CR47","unstructured":"Viatris (2025) New Zealand Consumer Medicine Information: PAXAM. https:\/\/www.medsafe.govt.nz\/consumers\/cmi\/p\/paxam.pdf"},{"issue":"2","key":"4433_CR48","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1080\/02791072.2023.2191610","volume":"56","author":"J Weleff","year":"2024","unstructured":"Weleff J, Anand A, Squeri M, Sieke R, Thompson NR, Barnett BS (2024) An analysis of benzodiazepine prescribing to primary care patients in a large healthcare system from 2019\u20132020. J Psychoactive Drugs 56(2):245\u2013256. https:\/\/doi.org\/10.1080\/02791072.2023.2191610","journal-title":"J Psychoactive Drugs"},{"key":"4433_CR49","unstructured":"Welsh Emerging Drugs and Identification of Novel Substances (2026) Sample Results. https:\/\/www.wedinos.org\/db\/samples\/"},{"issue":"6","key":"4433_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/wfs2.1416","volume":"3","author":"M Wilde","year":"2021","unstructured":"Wilde M, Auw\u00e4rter V, Moosmann B (2021) New psychoactive substances: designer benzodiazepines. WIREs Forensic Sci 3(6):1\u201323. https:\/\/doi.org\/10.1002\/wfs2.1416","journal-title":"WIREs Forensic Sci"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04433-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04433-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04433-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T09:31:50Z","timestamp":1786267910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-026-04433-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4433"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04433-9","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors do not report any conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}